A modular platform for targeted RNAi therapeutics

Ranit Kedmi(Tel Aviv University), Nuphar Veiga(Tel Aviv University), Srinivas Ramishetti(Tel Aviv University), Meir Goldsmith(Tel Aviv University), Daniel Rosenblum(Tel Aviv University), Niels Dammes(Tel Aviv University), Inbal Hazan‐Halevy(Tel Aviv University), Limor Nahary(Tel Aviv University), Shani Leviatan-Ben-Arye(Tel Aviv University), Michael Harlev(Tel Aviv University), Mark A. Behlke(Integrated DNA Technologies (United States)), Itai Benhar(Tel Aviv University), Judy Lieberman(Harvard University), Dan Peer(Tel Aviv University)

Nature Nanotechnology

January 29, 2018

10.1038/s41565-017-0043-5

Cited by 313

Abstract

Related Papers

Rational design of cationic lipids for siRNA delivery

Sean C. Semple, Akin Akinc, Jianxin Chen et al.|Nature Biotechnology|2010|1.8k

Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors

Erwei Song, Pengcheng Zhu, Sang‐Kyung Lee et al.|Nature Biotechnology|2005|1k

Cell type–specific delivery of siRNAs with aptamer-siRNA chimeras

James O McNamara, Eran R. Andrechek, Yong Wang et al.|Nature Biotechnology|2006|994

Knocking down disease: a progress report on siRNA therapeutics

Anders Wittrup, Judy Lieberman|Nature Reviews Genetics|2015|795

Ly6Chi Monocytes in the Inflamed Colon Give Rise to Proinflammatory Effector Cells and Migratory Antigen-Presenting Cells

Ehud Zigmond, Chen Varol, Júlia Farache et al.|Immunity|2012|720